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Abstract 
Background: After severe blunt chest trauma, the development of an acute lung injury (ALI) is often associated with 
severe or even lethal complications. Especially in multiple injured patients after blunt chest trauma ALI/ARDS [acute 
respiratory distress syndrome (ARDS)] is frequent. However, in the initial posttraumatic phase, inflammatory clinical 
signs are often not apparent and underlying changes in gene‑expression profile are unknown.
Methods: Therefore, inflammation in lung tissue following blunt chest trauma was characterized in a well‑defined 
bilateral lung injury model. Using DNA microarrays representing 9240 genes, the temporal sequence of blunt chest 
trauma‑induced gene‑expression patterns in lung tissue was examined.
Results: The results suggest an activation of a highly complex transcriptional program in response to chest trauma. 
Chest trauma led to elevated expression levels of inflammatory and coagulatory proteins (such as TNFα receptor, 
IL‑1α, IL‑1β, C3, NF‑κB and plasminogen activator). However, upregulation of proteins was found, usually incoherent 
of exerting effects in blunt thoracic trauma (pendrin, resistin, metallothionein and glucocorticoid‑induced leucine 
zipper). Furthermore, significant downregulation was observed as early as 10 min after trauma for cytokines and 
complement factors (LCR‑1, C4) as well as for intracellular signaling molecules (inhibitory protein phosphatase) and 
ion‑channels (voltage‑dependent Ca2+ channel).
Conclusions: Taken together, the provided global perspective of the inflammatory response following blunt chest 
trauma could provide a molecular framework for future research in trauma pathophysiology.
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Background
Severe trauma to the chest with pulmonary contusion 
still causes approximately a quarter of all civil trauma-
related deaths [1]. Especially for lung injury inflicted by 
blasts (e.g. in the crime/military setting), the underlying 
pathophysiology and development of the inflammatory 
response is still poorly understood [2]. Various biological 
mediators seem to play a central role in the pathophysiol-
ogy of blunt chest trauma, including cytokines, comple-
ment (e.g. C5a) and coagulation factors [3]. Persistent 
elevation of pro-inflammatory cytokines in the lungs 
with subsequent suppression (or increasing paralysis) of 
the immune system is associated with an enhanced risk 
for acute lung injury (ALI) progression and is known to 
increase mortality. We have previously demonstrated, 
that lung contusion is the major contributor to post-
traumatic inflammation even in combined injury and 
in the presence of hemorrhagic shock, suggesting that 
the degree of pulmonary inflammation is an impor-
tant determinant for the clinical course post-trauma [4]. 
Many cytokines and other pro-inflammatory mediators, 
such as complement activation products, involved in the 
development and progression of ALI are known to be 
regulated via the transcriptional regulatory factor nuclear 
factor (NF)-κB. Yet, ALI is a highly complex poly-etiolog-
ical syndrome, which cannot only be triggered by various 
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local damage (such as lung contusion, blunt chest trauma, 
pneumonia or ventilatory damage to the lung [2]), but it 
may also be triggered by limited remote injury (such as 
long bone fractures, head trauma) and also by different 
systemic insults such as large volume blood transfusions, 
burn injuries, shock, polytrauma [5], systemic inflam-
matory response syndrome (SIRS) and sepsis. However, 
the underlying changes in protein expression profiles are 
rather speculative. Therefore, in the present study, we 
used a 9240 element rat cDNA microarray to analyze pul-
monary gene-expression patterns in a well-characterized 
rat model of blunt chest trauma [6]. Various pro-inflam-
matory mediators are currently routinely measured in 
plasma in the face of a very dynamic and rapidly changing 
environment in trauma to assess the “trauma load” and 
serve as predictive markers for the patient´s course and 
outcome [7]. In contrast, data from and extrapolations 
to individual organs are hardly achievable in the clinical 
setting. Based on our blunt chest trauma model, microar-
ray analysis of pulmonary gene expression may provide 
important insights into the pulmonary pathophysiology 
after blunt chest trauma, which might ultimately help 
to mitigate or, perhaps, prevent the progression to ALI/
ARDS. Furthermore, the present findings identify poten-
tial new candidates and facilitate prediction of the clinical 




All investigative procedures and the animal facilities 
conformed with the Guide of Care and Use of Labora-
tory Animals published by the US National Institutes of 
Health. The study was approved by the regional animal 
care and use committee (Approval No. 784/2003). Adult 
pathogenic-free male Wistar rats (325–375  g, Charles 
River, Wilmington, MA, USA), were anesthetized with 
a mixture of 2.5  % sevoflurane (Sevorane TM Abbott, 
Wiesbaden, Germany) and 97.5 % oxygen (under contin-
uous flow of 3  l/min). The gas combination was applied 
by a mask covering the snout of the animal. To continue 
adequate analgesia after injury, buprenorphine (0.03 mg 
per kg body weight) was injected subcutaneously every 
6 h. Before and after surgery, rats had unrestricted access 
to food and water.
Blast‑induced bilateral lung injury
Blunt chest trauma was induced on anesthetized rats by 
a single blast wave centered on the thorax as previously 
described [6]. In surviving animals, no extrathoracic inju-
ries (such as liver rupture etc.) were found macro- and 
microscopically. The upper section of the device served 
as a pressure reservoir and was separated from the lower 
nozzle by a 50  µm Mylar TM polyester film (Du Pont, 
Bad Homburg, Germany). The pressure reservoir was 
connected to a storage tank of compressed air. Between 
both components an electronically releasable high-speed 
valve (Hee-D-24, FESTO, Esslingen, Germany) and a 
pressure reducing valve set to 13 bar (Zinser, Ebersbach, 
Germany) were interposed. By opening the high-speed 
valve, compressed air was delivered into the upper sec-
tion of the generator. When the pressure exceeded the 
resistance of the polyester diaphragm, the film ruptured 
towards the nozzle, releasing a well-defined single blast 
wave. The nozzle-chest-distance was strictly kept at 2 cm, 
leading to acute mortality rates of about 5 % (immediate 
cardiac rupture, posttraumatic apnea). Each blast wave 
was highly reproducible as assessed by a pressure trans-
ducer (Omega 100 psi, New Port Omega, Dechenpfronn, 
Germany) attached horizontally to the opening of the 
nozzle. Sham-treated animals were equally anesthetized 
and received equal volumes of PBS. The following time-
points were investigated post-trauma: sham, 10  min, 1, 
3, 6, 12 and 24 h. All time points and different treatment 
groups (sham, blunt chest trauma) consisted of n = 5–7 
per experimental condition.
Isolation of mRNA
At given time-points after trauma, lungs were flushed 
with 10  ml PBS to remove blood cells. Total RNA was 
extracted from lungs using Trizol reagent (Life Technolo-
gies, Grand Island, NY, USA) according to the manufac-
turer’s instructions and stored at −80  °C until further 
analysis. Control mRNA samples were isolated from 
sham animal lungs.
Microarray analysis
DNA microarray analysis of gene expression was done 
as described at [8] and by the Brown and Derisi Labs 
(available at http://www.microarray.org). The sequence-
verified cDNA clones of the rat cDNA microarray are 
available from Research Genetics (http://www.resgen.
com). Purified polymerase chain reaction products, gen-
erated using the clone inserts as template, were spot-
ted onto poly-l-lysine-coated microscope slides using 
an Omnigrid robotic arrayer (GeneMachines Inc., San 
Carlos, CA, USA) equipped with quill-type pins (Majer 
Precision Engineering, Tempe, AZ, USA). One full print 
run generated ~100 DNA microarrays. All chips have 
various control elements, which include human, rat, and 
yeast genomic DNAs, standard saline citrate, yeast genes, 
housekeeping genes, among others. In addition, we have 
separately obtained ~500 inflammation- and apopto-
sis-related cDNAs from Research Genetics to serve as 
independent controls for clone tracking and function 
as duplicates for quality control. Protocols for printing 
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and postprocessing of arrays are available in the pub-
lic domain (http://www.microarray.org). Once isolated, 
mRNA from both experimental and control organs were 
used as a template for cDNA generation using reverse 
transcriptase. Inclusion of amino allyl-dUTP in the 
reverse transcriptase reaction allowed for subsequent 
fluorescent labeling of cDNA using monofunctional 
N-hydroxy succinimidyl (NHS) ester dyes (as described 
[8]). The experimental cDNA sample was coupled to 
a monofunctional Cy5-NHS ester and the reference 
cDNA sample to a Cy3-NHS ester (Amersham, Arlington 
Heights, IL, USA). The labeled probes were then hybrid-
ized to 8K rat cDNA microarrays. Fluorescent images 
of hybridized microarrays were obtained using a Gene-
Pix 4000A microarray scanner (Axon Instruments, CA, 
USA).
Data analysis
Primary analysis was done using the Genepix software 
package. Images of scanned microarrays were grid-
ded and linked to a gene print list. Initially, data were 
viewed as a scatter plot of Cy3 versus Cy5 intensities. 
Cy3 to Cy5 ratios were determined for the individual 
genes along with various other quality control param-
eters (e.g. intensity over local background). The genepix 
software analysis package flags spots as absent based on 
spot characteristics (http://www.moleculardevices.com). 
Additionally, bad spots or areas of the array with obvious 
defects were manually flagged. Spots with small diam-
eters (<50 µm) and spots with low signal strengths <350 
fluorescence intensity units over local background in 
the more intense channel were discarded. Flagged spots 
were not included in subsequent analyses. Data were 
scaled such that the average median ratio values for all 
spots were normalized to 1.0 (done separately for each 
array). An arbitrary cut-off ratio of twofold was used 
to select genes as significantly up- or down-regulated 
relative to the control sample. Normalized fluorescence 
ratios of non-flagged array elements were uploaded to 
a Microsoft Access Database (Microsoft Corporation, 
Redmond, WA, USA). The data were log2 transformed 
and hierarchically clustered with average linkage cluster-
ing and visualized using the TreeView program. In some 
cases, inclusion thresholds were increased to focus the 
returned clusters.
Protein assays
All protein assays were analyzed using a commercially avail-
able ELISA kit in accordance with the manufacturer’s proto-
col (heme-oxygenase 1; ADI-EKS-810A; Enzo Life Sciences 
Inc, NY 11735, USA) (Metallothionein; E-EL-R0629; Elab-
science Biotechnology Co. Ltd., Wuhan, China) (Resistin; 
Fa. DRG Instruments Gmbh, Marburg, Germany).
Statistical analysis
All values of the microarray experiment were expressed 
as mean ±  SEM. Animal groups were individually que-
ried for genes that were differentially expressed in the 
trauma lungs as compared to negative control lungs. 
Gene expression was considered statistically significant 
when trauma group/control ratio was >2.0 (upregulation) 
or <0.5 (downregulation). For statistical evaluation of the 
protein analysis an unpaired t test (IBM SPSS Statistics 
20.0, SPSS Inc., IBM, Armonk, NY, USA) was assessed 
after testing of normal distribution. Results with p ≤ 0.05 
were considered statistically significant.
Results and discussion
Results
To facilitate access to the high numbers of screened 
genes, microarray findings were sorted into groups of dif-
ferent mediator systems, cascades and pathways known 
to be involved in inflammation.
Cytokines/chemokines
In line with evidence from the literature, transcriptional 
programs of pro-inflammatory cytokines/chemokines 
and/or their corresponding receptors were found to be 
upregulated during the course after blunt chest trauma 
(Fig.  1). Gene expression for IL-1α was found to be 
upregulated about threefold very early after trauma (1 h) 
while expression of IL-1β reached significant upregula-
tion after 12  h and persisted until 24  h. The genes for 
the TNFα-receptor (TNFα-R) displayed a robust upreg-
ulation 1 h through 6 h after blunt chest injury. It was 
found that chest trauma also seemed to decrease gene-
expression levels of some pro-inflammatory cytokines 
Fig. 1 Regulated genes encoding for various cytokines or their 
receptors at different time‑points after blunt chest trauma. Upregu‑
lation was defined as >2‑fold increase of gene expression, while 
downregulation was considered significant when expression 
levels <0.5 when being compared to sham lungs. LCR-1 leucocyte 
chemokine receptor, TNFα tumor necrosis factor α. Displayed are 
mean values ± SEM
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and chemokines with a significant decrease of the 
chemokine receptor LCR-1 at 1 and 12  h after trauma 
(Fig. 1).
Intracellular pathways
Trauma-induced transcriptional alterations of selected 
molecules involved in intracellular signaling are exhibited 
in Fig. 2. As early as 1 h after trauma, the G-protein cou-
pled receptor protein reached a significant upregulation 
(up to threefold; Fig. 2). MAPK-6 remained significantly 
elevated from 1  h until 6  h post-trauma. Over the full 
observation period, there were various intracellular sign-
aling molecules whose genomic expression was dimin-
ished after chest trauma (Fig.  2). E.g., expression of the 
inhibitory protein phosphatase was reduced 1–24 h after 
injury. MKP-21 showed significantly decreased levels 
over the whole observation period whereas for MKP-4 a 
trend towards elevated levels could be detected (data not 
shown).
Coagulation system
The coagulation system was one of the first biological 
cascades to respond to blunt chest trauma. Expression of 
the genes encoding for the plasminogen activator tissue 
and plasminogen activator urokinase receptor were sig-
nificantly increased 1–3  h after exposure to blunt chest 
trauma (Fig. 3).
NF‑κB family
One of the transcriptional key factors involved in the 
inflammation-triggered production of cytokines and 
chemokines is the nuclear transcription factor (NF)-κB. 
While gene expression of NF-κB light chain was 
upregulated as early as 10 min and 1 h post-trauma, the 
inhibitor (IκB) light chain, which regulates NF-kappa B 
by distinct mechanisms, did not show significant altera-
tions (Fig. 3).
Ion‑channels
Expression of the voltage-dependent calcium channel 
was decreased over the whole experimental period after 
trauma and almost abolished 3 h after trauma (Fig. 3).
The pendrin gene codes for the integral membrane 
protein SLC26A4 exchanging anions for chloride and 
is strongly expressed in tissues of the kidney, the inner 
ear and the thyroid. The expression rate of pendrin con-
stantly rose, reaching significant values after 6 h. In the 
latter course of trauma, pendrin further rose, reaching its 
peak 12 h after chest trauma (Fig. 3).
Complement system
Own previous results described an involvement of the 
powerful complement anaphylatoxin, C5a, in the patho-
genesis of blunt chest trauma [3]. Moreover, we observed 
significant systemic increases of C3a levels following lung 
contusion (unpublished data). In accordance with these 
findings, genomic expression of C3 was very significantly 
elevated 12 h after trauma (Fig. 4), while expression levels 
of another complement protein, C4, were little affected 
after chest trauma (Fig. 4).
Cytoprotective proteins
Various cytoprotective proteins, which have not been 
previously described in blast-induced blunt chest trauma 
showed significant alterations in the time-course of blunt 
chest trauma.
Five-fold upregulation was seen for cytoprotec-
tive heme-oxygenase 1 (HO-1). Heme-oxygenase 1 is a 
Fig. 2 Genes encoding for molecules involved in intracellular 
signaling following blunt chest trauma. Expression ratio of trauma 
lungs/sham lungs >2 was defined as upregulation, a ratio of <0.5 
as downregulation. MAPK mitogen activated protein kinase, MKP 
mitogen activated protein kinase phosphatase. Displayed are mean 
values ± SEM
Fig. 3 Lung gene expression involving proteins from the coagulation 
system, the NF‑κB family, and ion‑channels at different time‑points 
after chest trauma. Expression ratio of trauma lungs/sham lungs 
>2 was defined as upregulation, a ratio <0.5 as downregulation. 
Displayed are mean values ± SEM
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stress-responsive enzyme that catabolizes heme into 
carbon monoxide (CO), biliverdin and iron, thereby pro-
viding antioxidant, anti-apoptotic, anti-inflammatory 
and immunomodulatory properties. While remaining 
at normal levels directly after trauma, a robust increase 
occurred 3  h after trauma, sustained 24  h post-trauma, 
with the highest elevation 12 h after trauma.
Another gene that revealed enhanced expression rates 
after trauma was the glucocorticoid-induced leucine zip-
per (GILZ). GILZ mediates glucocorticoid actions, such 
as binding and inhibiting of NF-κB, modulation of T-lym-
phocyte activation, interleukin production, apoptosis 
and cell proliferation. As early as 10  min after trauma, 
significant upregulation was found, peaking at 1  h after 
the insult. Upregulation persisted until 6  h post-trauma 
returning to normal levels after 12 and 24 h (Fig. 5).
Resistin, only recently described as an adipocyte-
specific hormone being related to insulin resistance in 
obese mice, showed by far the most upregulated expres-
sion values. The expression rate for resistin significantly 
increased 3 h after trauma with maximum levels at 12 h 
(up to sixfold), decreasing until 24  h after induction of 
blunt chest trauma.
The group of metallothionein protein are metal binding 
proteins that play a role in metal homeostasis, detoxifica-
tion and removement of oxygen radicals. Metallothionein 
1 expression significantly increased early (1–3  h) after 
trauma.
Detailed analysis of HO‑1 upregulation
Evaluation of heme-oxygenase 1 showed a strong correla-
tion with the microarray data. Significantly elevated lev-
els of HO-1 were found after 3 (p = 0.015), 6 (p < 0.001) 
and 24 h (p = 0.038) (Fig. 6), while the result after 12 h 
lacked significance (p  =  0.063). Metallothionein 1 also 
showed increased, but not significantly elevated levels 
after 10  min (p =  0.101) and 6  h (p =  0.216) (data not 
shown). However, for resistin, no differences and no cor-
relation with the massive upregulation in the microrarray 
analysis was seen.
Discussion
While blunt chest trauma is a common associated injury 
in multiple injured patients and is accompanied with 
high morbidity [1], we are only beginning to understand 
the pathophysiological changes following blunt lung 
injury. In the present study, we seek to provide a global 
perspective of the inflammatory response following blunt 
chest trauma and present a molecular framework for 
future research in this area. While the gene expression of 
inflammatory proteins and members of the coagulation/
complement cascade showed expected values, proteins 
which are currently not the focus of research in blunt 
Fig. 4 Expression changes of components of the complement 
system demonstrate upregulation of C3 and little change in C4. 
Expression ratio of trauma lungs/sham lungs >2 was defined as 
upregulation, a ratio <0.5 as downregulation. Displayed are mean 
values ± SEM
Fig. 5 Expression changes of specific proteins in the lungs during 
the time‑course of blunt chest trauma. Expression ratio of trauma 
lungs/sham lungs >2 was defined as upregulation, a ratio <0.5 as 
downregulation. HO-1 heme‑oxygenase 1, GILZ glucocorticoid‑
induced leucine zipper. Displayed are mean values ± SEM
Fig. 6 ELISA‑based analysis of heme‑oxygenase 1 (HO‑1) during the 
time‑course of blunt chest trauma in ng/mg protein. Displayed are 
mean values ± SEM; *p < 0.05
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chest trauma (especially cytoprotective proteins) showed 
significantly upregulated levels.
Cytokines/chemokines
Increased levels of IL-1β and IL-1α have been described 
to be involved in the pathogenesis of ARDS and subse-
quent pulmonary fibrosis [9]. In line, IL-1β has been 
reported to be increased in brochoalveolar lavage (BAL) 
fluids after blunt chest trauma [10], a result which was 
could be confirmed (Fig.  1). The generally accepted 
involvement of TNFα-R in the inflammatory cascade was 
also found to be upregulated in the present study. Over-
expression of TNF-α-R seemed to increase the receptor 
for the complement activation product C5a (C5aR) and 
to be crucially involved in recruitment of inflammatory 
cells, as TNF-α-R-knockout mice displayed a decreased 
neutrophil rolling and adhesion [11].
Intracellular pathways
MAPK phosphatases (MKPs) are capable of dephos-
phorylation of activated MAPKs. This results in inac-
tivation of MAPKs with effective abolishment of their 
physiological functions. During the last years, MKPs 
have been shown to be crucially involved in the regula-
tion of immune responses. In this regard, MKPs are able 
to modulate the production of pro- and anti-inflamma-
tory cytokines, innate immune cell viability, the func-
tion of antigen-presenting cells and the adaptive immune 
responses through regulation of cytokine biosynthesis 
and cell proliferation. Moreover, MKPs serve as a feed-
back control mechanism of MAPK pathways [12]. In the 
present study, the MAPKs were found to be upregulated 
almost over the whole observation period while MKPs 
showed ambiguous results with elevated (not signifi-
cant) levels after 1  h (MKP-4) and diminished amounts 
over the whole experiment for MKP-21 (Fig.  2). MPKs 
are known to be induced by hydrogen peroxide [13], 
which might originate from transmigrated neutrophils 
and macrophages involved in the inflammatory response 
following blunt chest trauma. In accordance, MPKs have 
been described to be massively upregulated in response 
to hypoxia [14], which has been described to occur in the 
early phase post-trauma in current model [6]. Moreover, 
MPKs seems to play a critical role in mediating stress 
responsiveness and regulating inflammatory response in 
macrophages [15].
Coagulation system
One of the very early genomic alterations due to blunt 
chest trauma are the changes in the coagulation system 
(Fig.  3). The plasminogen activator urokinase receptor, 
which was found to be significantly increased 1–3 h after 
trauma, has been described to be upregulated by IL-1β 
and TNF-α [16], both of which have been reported to be 
increased early following clinical and experimental blunt 
chest trauma [10]. In addition, plasminogen activator has 
been reported to regulate recruitment of white blood 
cells via upregulation of integrins such as vascular cell 
adhesion molecule (VCAM) and intracellular adhesion 
molecule (ICAM) [17], and seems to be a potent chem-
oattractant for phagocytes. Finally, increased levels of 
plasminogen activator have been found to be involved in 
the pathogenesis of lung fibrosis, a classical feature of late 
stage ARDS [18].
NF‑κB family
Especially early after trauma (10  min and 1  h), NF-κB 
light chain was one of the highest upregulated proteins in 
our microarray within the first 3 h. After 3 h expression 
levels gradually dropped.
Early elevation of NF-κB is not surprising, as it is 
known, that NF-κB represents a transcriptional factor 
binding to promoter regions of pro-inflammatory genes 
such as IL-1β, IL-6, IL-8 and TNF-α being necessary for 
the production of these crucial inflammatory cytokines 
[19]. Interestingly, the NF-κB inhibitor was unaltered 
after blunt TXT.
Ion‑channels
The main function of pendrin, which was highly regu-
lated after thoracic trauma (TXT), is the exchange of ani-
ons for chloride. Pendrin is strongly expressed in tissues 
of the kidneys, the inner ear and the thyroid gland [20]. In 
kidneys, pendrin maintains acid–base balance by secret-
ing HCO3− in exchange of Cl−. In the inner ear, pendrin 
is of major importance for the generation of the endo-
lymphatic fluid while in the thyroid gland, pendrin func-
tions as a Cl−/I− exchanger for maintaining the iodide 
efflux into the follicular lumen [20]. It has been shown, 
that pendrin is upregulated in airway epithelium upon 
inflammatory stimulation of IL-4, IL-13 or antigen expo-
sure [21]. In the last years, increasing evidence has been 
found that pendrin is upregulated and may be involved 
in the pathogenesis of pulmonary diseases like asthma or 
chronic obstructive pulmonary disease (COPD) [20]. In 
both clinical entities pendrin has been shown to regulate/
increase the viscosity of the airway fluid by its distinct 
function as anion/chloride exchanger, therefore contrib-
uting to asthma and COPD exacerbations [22]. Besides 
the possible upregulation due to the blunt thoracic 
trauma as inflammatory stimulus, the pathogenic role for 
pendrin in this injury model remains to be elucidated.
Complement system
We found that, C3 was strongly upregulated on a 
genomic level with small changes in C4 (Figs. 1, 4). The 
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local production of complement component C3 by 
monocytes appears to be regulated, in part, by IL-1β and 
INF-γ [23]. It is tempting to speculate that the observed 
upregulation of C3 in lungs after trauma might have been 
IL1β-mediated. Moreover, systemic infections like sep-
sis were found to activate complement, consuming C3 
and C4 and generating enhanced levels of C3a and C4a 
especially in patients succumbing to sepsis [24]. In our 
study, genomic expression of C4 was downregulated 10 
min and 12 h post-trauma (Fig. 4). It may be speculated, 
that this decrease depicts the downregulation of the clas-
sical pathway as for traumatic injuries the main activity 
of the complement system is generated via the alterna-
tive pathway. Interestingly, no alteration of complement 
factor 5 was found in the microarray analysis. Based on 
excess of key complement components in the blood (such 
as C3 and C5), it is noteworthy that posttraumatic ana-
phylatoxin generation (such as C5a) with subsequent 
biological consequences may occur without significant 
trauma-induced alteration of their genetic expression.
Cytoprotective proteins
Various cytoprotective genes were upregulated as a sign 
of host protection against exogenous detrimental effects 
of the blast-induced blunt chest trauma.
A significant increase was seen for heme-oxygenase 1 
(HO-1). It has been shown, that HO-1 exerts protective 
effects in the liver e.g. in transplanted liver grafts as well 
as after ischemia/reperfusion injuries, spinal cord inju-
ries and in acute kidney injury [25]. To our knowledge, 
no data exist on the role of HO-1 in experimental blunt 
chest trauma. While some beneficial effects for HO-1 
were found in ALI after experimental sepsis [26], an 
increase of HO-1 seems to have negative effects on the 
outcome after acute bacterial infection of the lung in 
pneumonia-induced sepsis potentially by reducing neu-
trophil function and host defense [27].
The glucocorticoid-induced leucine zipper (GILZ) was 
significantly elevated from 10  min post-trauma until 
6  h. GILZ was first discovered in the late 1990s. Exten-
sive studies discovered manifold protein functions, espe-
cially modulation of T-lymphocyte activation, interleukin 
production, apoptosis and cell-proliferation [28]. More 
recently, besides expression in various tissues, differ-
ent functions of the GILZ have been described such as 
involvement in the epithelial Na2+ channel (ENaC)-medi-
ated Na2+ transport in the kidneys. After glucocorticoid 
stimulus, upregulation in airway epithelium and mesen-
chymal stem cells was found [28]. Only recently, GILZ 
was proposed as an endogenous inflammatory inhibitor 
in arthritis with potential therapeutic potency [29]. In 
the traumatic setting of spinal cord injury, GILZ overex-
pression in T-lymphocytes was proposed to inhibit tissue 
damage and tissue inflammation [28]. Taken together, 
GILZ seems to inhibit damage and inflammation in sev-
eral inflammatory diseases with a new role even in blunt 
thoracic trauma.
In the present study, Resistin exhibited elevated expres-
sion levels at 3 h remaining upregulated until the end of 
the experiment. Whereas in humans resistin is mainly 
expressed in monocytes, in mice it is also found in adi-
pocytes [30]. Consecutively, alternative functions apart 
from insulin resistance and diabetes have been described: 
Resistin inherits a strong pro-inflammatory potential 
through induction of the cytokine cascade and vice versa 
induction of resistin by pro-inflammatory cytokines has 
also been demonstrated. Manifold interactions and pos-
sible roles for resistin in the pathogenesis of diseases such 
as atherosclerosis, rheumatoid arthritis and asthma were 
shown [31]. Up to now, only little is known about its role 
in traumatic lung tissue damage. While the exact role of 
resistin in the majority of involved human pathologies 
remains unclear, regulation of resistin may be regarded as 
a potential biomarker for the activity of the disease or the 
extent of organ dysfunction [32].
The protein metallothionein-1 (MT-1) was significantly 
elevated 1–3 h after trauma. Besides the main function of 
metal homeostasis, detoxification and removal of oxygen 
radicals, further roles include protection against DNA 
damage and binding/exchange of heavy metals such as 
zinc, copper and cadmium [33]. While MT-1 and 2 can be 
detected ubiquitally, expression of MT-3 is limited to the 
brain and male sexual organs. In contrast to the classical 
functions of MT-1/2, MT-3 plays its major role in develop-
ment and programmed apoptosis of brain-cells. In the last 
years, various studies documented the anti-inflammatory 
and protective role of metallothionein in tissue trauma. 
Besides accelerated wound healing, studies demonstrated 
a protective role of MT in brain tissue and proposed ther-
apeutic potential in neurodegenerative diseases [34]. A 
protective role in lung tissue was demonstrated by Inoue 
et al. with levels of MT correlating with the degree of pul-
monary inflammation in bacterial- or antigen-related ALI 
[35]. In summary, upregulation of metallothionein clearly 
represents a marker for the amount of inflammation after 
blunt chest trauma and can be regarded as a mechanism 
of the host to limit tissue damage.
Conclusions
Taken together, the observed transcriptional altera-
tions in the lungs after blunt chest trauma displayed a 
strong “yin-yang”-like dualism. While some cytokines 
(like IL-1α and IL-1β) were found to be upregulated, 
other members of the chemokine family (LCR-1) were 
downregulated. Similarly, some components of the com-
plement system exhibited a selective pattern (e.g. C3 
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and C4). Isoforms of MKPs showed ambiguous results 
with upregulation of the one and downregulation of the 
other protein. Similar findings of gene dualism were also 
reported to be imprinted in the molecular signature of 
sepsis [8]. Various described proteins (e.g. HO-1, GILZ, 
resistin) have been first described here to be upregulated 
during blunt chest trauma-induced lung inflammation.
The main limitation of the study arises from its study 
design. With a genomic analysis no evidence of an in vivo 
upregulation on protein level can be made. Therefore, 
further analysis of the alteration on protein levels of rel-
evant genes should be performed. This was of course 
assessed by the incorporated ELISA-based analysis of the 
proteins heme-oxygenase 1, metallothionein and resis-
tin. Sadly, further protein analyses were not possible as 
commercially available ELISAs for the relevant proteins 
are scarce for rats. Therefore, future studies should focus 
on genomic analysis in humans with consecutive protein 
analysis to extend our knowledge and understanding of 
blunt chest trauma.
Understanding, on a genomic scale, how an organism 
responds to severe blunt chest trauma may contribute to 
an improved clinical outcome and might ultimately put 
new promising treatment modalities on the horizon.
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